Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$21.9M |
| 2 |
Microsoft
MSFT
|
+$16.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$12.8M |
| 4 |
Starbucks
SBUX
|
+$12.3M |
| 5 |
Procter & Gamble
PG
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$15.7M |
| 2 |
CrowdStrike
CRWD
|
+$9.68M |
| 3 |
Cisco
CSCO
|
+$9.66M |
| 4 |
S&P Global
SPGI
|
+$7.27M |
| 5 |
Stryker
SYK
|
+$6.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.65% |
| 2 | Consumer Discretionary | 14.21% |
| 3 | Healthcare | 10.61% |
| 4 | Financials | 9.65% |
| 5 | Consumer Staples | 8.97% |
Similar funds
Bayesian Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Bayesian Capital Management held 1,150 positions worth $931M, up 15% from $808M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Bayesian Capital Management deployed $72.6M of net new capital in Q2 2023, opening 406 new positions and adding to 162 existing holdings. Its largest new stake was NVIDIA: 660,000 shares worth $27.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was S&P Global, an estimated $7.27M trimmed.
- Bayesian Capital Management's largest Q2 2023 buy was NVIDIA: 660,000 shares worth $27.9M.
- Bayesian Capital Management added most to Coca-Cola in Q2 2023, an estimated $10.9M increase.
- Bayesian Capital Management's biggest Q2 2023 reduction was S&P Global, cutting an estimated $7.27M.
- Bayesian Capital Management fully exited Tesla in Q2 2023, selling an estimated $15.7M.
- Bayesian Capital Management's ten largest holdings make up 15% of its $931M portfolio in Q2 2023.
- Bayesian Capital Management opened 406 new positions and closed 401 in Q2 2023.
- Bayesian Capital Management's portfolio value rose 15% quarter-over-quarter to $931M.
Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.